Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > RELEASE NEXT NEWS AT 4PM PLEASE

<< Previous

Bullboard Posts

Next >>

Comment by retiredRIAon Dec 15, 2021 7:38pm

168 Views

Post# 34235011

RE:RELEASE NEXT NEWS AT 4PM PLEASE

Reality.......Amen and Amen to your comments! I am in the states but on several microcap Stockhouse Bullboards. Today I gave an example of a undervalued stock (TH, or THTX to us in US) and after several exchanges on the bullboard, he said it looked really good and "took a flyer" & bought some. It all started when someone asked me thru this Bullboard if I liked any other small Canadian companys, knowing I was in the business. Just think what we could do if we had good news! Besides, I have many friends from my fee only advisory firm I sold in 2014. So, Paul, let us HELP YOU!

<< Previous

Bullboard Posts

Next >>

Level up your trading with BMO InvestorLine’s enhanced features